AsiaIPEX is a one-stop-shop for players in the IP industry, facilitating IP trade and connection to the IP world. Whether you are a patent owner interested in selling your IP, or a manufacturer looking to buy technologies to upgrade your operation, you will find the portal a useful resource.

Improved Treatment of Keloids and Other Cutaneous Fibrotic Diseases

Technology Application
Treating keloid scars
Detailed Technology Description
Scarring is a widespread problem for patients of all walks of life. Patients with scars can encounter substantial social and psychological problems. Certain types of scarring can be particularly noticeable because they become raised after healing. These types of scars are characterized as hypertrophic or keloid scars. Keloid scarring is particularly problematic because the scar spreads beyond the margins of the original wound and invades surrounding skin. Ultraviolet phototherapy is currently used to treat some fibrotic skin diseases, however, this causes DNA damage associated with skin cancers. Researchers at UC Davis propose a method of treating keloid scars by administering specific doses of LED infrared or red light. Preliminary studies in vitro show that red light at specific wavelengths and dosages can be effective in decreasing fibroblast proliferation and migration. Researchers envision that the preliminary findings will serve as the foundation for future LED-based red and infrared light management of keloid and other scars.
Application No.
9861832
Others

Features/Benefits

  • Non-invasive
  • Low-cost
  • Safe for patient use at home
  • Portable
  • Easy to use
  • Small, handheld size

Tech ID/UC Case

23101/2013-520-0


Related Cases

2013-520-0

*Abstract

Researchers at University of California, Davis have discovered that light emitting diode (LED) generated red light and infrared light can modulate skin cell functions associated with skin fibrosis.

*IP Issue Date
Jan 9, 2018
*Principal Investigator

Name: R. Rivkah Isseroff

Department:


Name: Jared Jagdeo

Department:


Name: Andrew Mamalis

Department:


Name: Neil Brody

Department:


Name: Hadar Lev-Tov

Department:


Name: Daniel Siegel

Department:

Country/Region
USA

For more information, please click Here
Mobile Device